With help from No­var­tis and Sanofi, Neu­roVia heads to the clin­ic armed with a $14M round

The cor­po­rate ven­ture arms of No­var­tis and Sanofi have joined hands to back a $14 mil­lion Se­ries A for a vir­tu­al start­up called Neu­roVia …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA